Tyler Mathisen co-anchors CNBC's "Power Lunch" (M-F, 1PM-3PM ET) one of the network's longest running program franchises, as well as "Nightly Business Report," an award-winning evening business news program produced by CNBC for U.S. public television. In 2014, NBR was named best radio/TV show by the Society of American Business Editors and Writers (SABEW).
Previously, Mathisen was managing editor of "CNBC Business News," responsible for directing the network's daily content and coverage. He had been the co-anchor of CNBC's "Closing Bell."
Mathisen has reported one-hour documentaries for the network including "Best Buy: The Big Box Fights Back," "Supermarkets Inc: Inside a $500 Billion Money Machine" and "Death: It's a Living." Mathisen was also host of the CNBC series "How I Made My Millions."
Before joining CNBC in 1997, Mathisen spent 15 years as a writer, senior editor and top editor for Money magazine. Among other duties, he supervised the magazine's mutual funds coverage, its annual investment forecast issue and its expansion into electronic journalism, for which it won the first-ever National Magazine Award for New Media in 1997.
In 1993, Mathisen won the American University-Investment Company Institute Award for Personal Finance Journalism for a televised series on "Caring for Aging Parents," which aired on ABC's "Good Morning America." Mathisen served as money editor of "GMA" from 1991 to 1997. He also won an Emmy Award for a report on the 1987 stock market crash that aired on New York's WCBS-TV.
A native of Arlington, Va., Mathisen graduated with distinction from the University of Virginia.
Follow Tyler Mathisen on Twitter @TylerMathisen.
Vishnu Lekraj, Morningstar senior equity analyst, discusses the role of the pharmacy benefit managers, or PBMs, and whether the "middlemen" are the ones to blame for drug price hikes.
Suzy Welch, LinkedIn contributing editor, discusses Mylan CEO Heather Bresch and what she had to say about the controversy surrounding Mylan's pricing of the EpiPen.
Shares of Clovis surge on positive FDA news, CNBC's Melissa Lee reports.
Jacob Monty, Houston-based immigration attorney and GOP activist, shares his take on Donald Trump's change of tone on immigration.
How is the EpiPen outrage impacting families, parents and children who need these products as protection against fatal allergy attacks? CNBC's Kate Kelly and Sue Herera discuss how its affecting their own children.
Doug Yearley, Toll Brothers CEO, discusses his company's earnings report, new home sales data and the state of the U.S. economy.
Having treated over a dozen cases already, Dr. Christine Curry, University of Miami, describes what it is like to treat pregnant women with Zika.
A new report forecasts home remodeling this year will top records set during the housing boom. CNBC's Brian Sullivan discusses. Robert Wetenhall, RBC Capital Markets Homebuilding and Building Products analyst, and Todd Tomalak, John Burns Consulting VP, weigh in.
Kyle Cooper, Ion Energy Group, shares his take on the price of oil, which is dropping below $48 a barrel after a week of gains.
Scott McNealy, former Sun Microsystems CEO and co-founder of Wayin, discusses why he thinks our education system is failing, and possible solutions for this problem.